Application 020655
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALORA | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.05MG/24HR | No | No |
| 002 | ALORA | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.075MG/24HR | No | No |
| 003 | ALORA | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.1MG/24HR | No | No |
| 004 | ALORA | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.025MG/24HR | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020655-001 | ALORA | ESTRADIOL | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | ||
| N020655-002 | ALORA | ESTRADIOL | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | ||
| N020655-003 | ALORA | ESTRADIOL | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | ||
| N020655-004 | ALORA | ESTRADIOL | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020655-001 | ALORA | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N020655-002 | ALORA | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N020655-003 | ALORA | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N020655-004 | ALORA | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N020655-001 | ALORA | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N020655-002 | ALORA | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N020655-003 | ALORA | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N020655-004 | ALORA | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N020655-001 | ALORA | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N020655-002 | ALORA | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N020655-003 | ALORA | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N020655-004 | ALORA | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020655-001 | ALORA | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020655-002 | ALORA | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020655-003 | ALORA | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020655-004 | ALORA | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020655-001 | ALORA | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020655-002 | ALORA | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020655-003 | ALORA | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020655-004 | ALORA | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020655-001 | ALORA | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020655-002 | ALORA | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020655-003 | ALORA | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020655-004 | ALORA | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020655-001 | ALORA | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020655-002 | ALORA | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020655-003 | ALORA | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020655-004 | ALORA | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020655-001 | ALORA | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020655-002 | ALORA | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020655-003 | ALORA | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020655-004 | ALORA | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020655-001 | ALORA | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020655-002 | ALORA | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020655-003 | ALORA | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020655-004 | ALORA | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020655-001 | ALORA | 0.05MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020655-002 | ALORA | 0.075MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020655-003 | ALORA | 0.1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 1996-12-20 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020655-004 | ALORA | 0.025MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2002-04-05 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N020655-001 | BX | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020655-002 | BX | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020655-003 | BX | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020655-004 | BX | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020655-001 | BX | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020655-002 | BX | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020655-003 | BX | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020655-004 | BX | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N020655-001 | BX | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N020655-002 | BX | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N020655-003 | BX | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N020655-004 | BX | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N020655-001 | BX | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N020655-002 | BX | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N020655-003 | BX | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N020655-004 | BX | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N020655-001 | BX | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N020655-002 | BX | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N020655-003 | BX | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N020655-004 | BX | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N020655-001 | BX | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N020655-002 | BX | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N020655-003 | BX | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N020655-004 | BX | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N020655-001 | BX | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N020655-002 | BX | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N020655-003 | BX | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N020655-004 | BX | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N020655-001 | BX | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N020655-002 | BX | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N020655-003 | BX | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N020655-004 | BX | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Estradiol | ESTRADIOL | Northwind Health Company, LLC | f6caf47a-1917-c493-e053-6394a90af63e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Northwind Health Company, LLC | f6cb38ab-fdff-9c07-e053-6294a90ad59a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| ESTRADIOL | ESTRADIOL | Northwind Health Company, LLC | f76aff99-f415-9045-e053-6294a90afd51 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Teva Pharmaceuticals USA, Inc. | c94738ff-dece-4fb6-bb44-4f8832a45f38 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Alvogen Inc. | 0178a92c-62b1-d5cf-cf54-2c85af88a74a | 2025-11-25 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | NorthStar Rx LLC | 1c2cd11a-e010-20b2-e063-6294a90a52d5 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol Vaginal | ESTRADIOL | Padagis Israel Pharmaceuticals Ltd | f76232ed-b109-43d1-bf2e-d41b6420c37d | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Bryant Ranch Prepack | ff3bcb07-f6fe-4582-948a-21dbf1e55f55 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| ESTRADIOL VAGINAL INSERTS | ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 86620f6c-fd02-40df-98d5-3048dcd92c37 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol Vaginal | ESTRADIOL | Bryant Ranch Prepack | f3806b5d-ebd6-43b4-adfa-a1fe86d80642 | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | f3a77482-f490-f350-e053-2a95a90ad8cb | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| ESTRADIOL VAGINAL INSERTS | ESTRADIOL | Aurobindo Pharma Limited | 6247e329-e20e-4ea5-9cc1-b593bd494577 | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | NuCare Pharmaceuticals,Inc. | c8ac2e13-58d5-4e70-e053-2995a90aff04 | 2025-09-22 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| ESTRADIOL VAGINAL INSERTS | ESTRADIOL | NorthStar Rx LLC | ad203bfd-28da-45a3-b9c0-7f886eb03634 | 2025-08-08 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | e962e36d-5d84-4b39-9bdf-e5f9a264b82a | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | 13f9c41b-417c-45e4-9a59-baf774fca78d | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| ESTRADIOL VAGINAL | ESTRADIOL | Encube Ethicals, Inc. | 1c61e837-4196-4b4d-9545-96b2d7c66f13 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | e7e6da3b-8485-1382-61c9-e9b369018b98 | 2025-06-23 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4 | 2025-06-23 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Coupler LLC | 37c99e4d-fb0d-0e6e-e063-6394a90a69c8 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0023-5885 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5885 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5885 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5885 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5885 | Alora | Estradiol Transdermal System | Allergan, Inc. | NDA | Current |
| 0023-5886 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5886 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5886 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5886 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5886 | Alora | Estradiol Transdermal System | Allergan, Inc. | NDA | Current |
| 0023-5887 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5887 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5887 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5887 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5887 | Alora | Estradiol Transdermal System | Allergan, Inc. | NDA | Current |
| 0023-5888 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5888 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5888 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5888 | Alora | Estradiol | Allergan, Inc. | NDA | Current |
| 0023-5888 | Alora | Estradiol Transdermal System | Allergan, Inc. | NDA | Current |
| 52544-471 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-471 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-471 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-471 | Alora | Estradiol Transdermal System | Actavis Pharma, Inc. | NDA | Current |
| 52544-472 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-472 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-472 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-472 | Alora | Estradiol Transdermal System | Actavis Pharma, Inc. | NDA | Current |
| 52544-473 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-473 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-473 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-473 | Alora | Estradiol Transdermal System | Actavis Pharma, Inc. | NDA | Current |
| 52544-884 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-884 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-884 | Alora | Estradiol | Actavis Pharma, Inc. | NDA | Current |
| 52544-884 | Alora | Estradiol Transdermal System | Actavis Pharma, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82164 | SUPPL | 2025-05-08 |
| 82260 | SUPPL | 2025-05-05 |
| 77530 | SUPPL | 2024-02-16 |
| 77517 | SUPPL | 2024-02-16 |
| 62369 | SUPPL | 2020-03-31 |
| 62367 | SUPPL | 2020-03-31 |
| 50261 | SUPPL | 2017-11-02 |
| 35078 | SUPPL | 2005-05-20 |
| 25447 | SUPPL | 2005-05-20 |
| 41523 | SUPPL | 2004-05-27 |
| 12923 | SUPPL | 2003-12-01 |
| 25446 | SUPPL | 2003-11-26 |
| 12924 | SUPPL | 2002-04-05 |
| 2998 | SUPPL | 2002-04-05 |